Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy-Reference-Cited by-同舟云学术

Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy

Published:2015-07-14 Issue:9 Volume:90 Page:E181-E182
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Breccia Massimo¹,Stefania de Propris Maria¹,Molica Matteo¹,Colafigli Gioia¹,Minotti Clara¹,Diverio Daniela¹,Latagliata Roberto¹,Guarini Anna¹,Lo-Coco Francesco²³,Foà Robin¹

Affiliation:

1. Division Hematology; Department of Cellular Biotechnologies and Hematology; Sapienza University; Rome Italy

2. Department of Biomedicine and Prevention; University Tor Vergata; Rome Italy

3. Laboratory of Neuro-Oncohematology; Santa Lucia Foundation; Rome Italy

Publisher

Wiley

Subject

Hematology

Reference19 articles.

1. The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment;Lo Coco;Hematology Am Soc Hematol Educ Progr,2006

2. Acute promyelocytic leukemia: From highly fatal to highly curable;Wang;Blood,2008

3. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups;Sanz;Blood,2000

4. . Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: A multicentre study by the PETHEMA group;Sanz;Blood,2004

5. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: Results of the AIDA-2000 trial of the GIMEMA group;Lo Coco;Blood,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PML‐RARA transcript levels at the end of induction therapy are associated with prognosis in non‐high‐risk acute promyelocytic leukaemia with all‐ trans retinoic acid plus arsenic in front‐line therapy: long‐term follow‐up of a single‐centre cohort study;British Journal of Haematology;2021-08-17

2. Increased body mass index is a risk factor for acute promyelocytic leukemia;eJHaem;2021-01-06